News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Ann S.M. Harada, MPH

Articles by Ann S.M. Harada, MPH

Predicting the Probability of Achieving NCEP LDL-C Treatment Goals Using HMG-CoA Reductase Inhibitor Monotherapy

ByAnn S.M. Harada, MPH,Michael B. Nichol, PhD

August 1st 1998

Latest Updated Articles

Predicting the Probability of Achieving NCEP LDL-C Treatment Goals Using HMG-CoA Reductase Inhibitor Monotherapy
Published: August 1st 1998 | Updated:

Trending on AJMC

Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure

5 Things to Know as Flu Season Begins

FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis

Top 5 Infectious Disease Pieces of 2025

Top 5 Ovarian Cancer Articles of 2025

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.